This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immunocore Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Pedro Cuadrado Rodenas: Innovator in Binding Molecules
Introduction
Pedro Cuadrado Rodenas is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules that have potential applications in treating malignant diseases.
Latest Patents
Pedro holds a patent for his invention related to binding molecules. This patent involves T cell receptor (TCR) variable domains that can bind to a PIWIL1 peptide-HLA complex. The implications of this invention are profound, as it opens new avenues for therapeutic interventions in cancer treatment.
Career Highlights
Pedro is currently associated with Immunocore Limited, a company that focuses on innovative therapies for cancer and other diseases. His work at Immunocore has positioned him as a key player in the biotechnology sector, contributing to advancements that could change the landscape of cancer treatment.
Collaborations
Pedro collaborates with talented professionals in his field, including Nicole Mai and Arnaud Techine. These collaborations enhance the research and development efforts at Immunocore, fostering an environment of innovation and discovery.
Conclusion
Pedro Cuadrado Rodenas exemplifies the spirit of innovation in biotechnology through his groundbreaking work on binding molecules. His contributions are paving the way for new treatments in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile